{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:35Z","timestamp":1792783295228,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82204125"],"award-info":[{"award-number":["82204125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772170"],"award-info":[{"award-number":["81772170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["No. 2022YFC3400700"],"award-info":[{"award-number":["No. 2022YFC3400700"]}]},{"name":"Special Foundation for Science and Technology Basic Research Program","award":["2019FY101103"],"award-info":[{"award-number":["2019FY101103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12072-024-10750-x","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T03:14:24Z","timestamp":1732418064000},"page":"156-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Global, regional, and national epidemiology of hepatoblastoma in children from 1990 to 2021: a trend analysis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2275-3575","authenticated-orcid":false,"given":"Chengnan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luojia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"10750_CR1","doi-asserted-by":"publisher","unstructured":"Chengzhan Zhu, Bingzi Dong, Xin Chen, Qian Dong. Diagnosis and Treatment of Hepatoblastoma: An Update. In: Vijay Gayam, Omer Engin, editors. Liver Pathology [Internet]. Rijeka: IntechOpen; 2020 [cited 2024 May 20]. p. Ch. 1. Available from: https:\/\/doi.org\/10.5772\/intechopen.90830","DOI":"10.5772\/intechopen.90830"},{"key":"10750_CR2","first-page":"62","volume":"39","author":"J Feng","year":"2019","unstructured":"Feng J, Polychronidis G, Heger U, Frongia G, Mehrabi A, Hoffmann K. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun (Lond). 2019;39:62","journal-title":"Cancer Commun (Lond)"},{"key":"10750_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11912-022-01230-2","volume":"24","author":"PV Wu","year":"2022","unstructured":"Wu PV, Rangaswami A. Current approaches in hepatoblastoma-new biological insights to inform therapy. Curr Oncol Rep. 2022;24:1209\u20131218","journal-title":"Curr Oncol Rep"},{"key":"10750_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/jhep.2003.50375","volume":"38","author":"A Darbari","year":"2003","unstructured":"Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38:560\u2013566","journal-title":"Hepatology"},{"key":"10750_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cncr.23169","volume":"112","author":"AM Linabery","year":"2008","unstructured":"Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992\u20132004). Cancer. 2008;112:416\u2013432","journal-title":"Cancer"},{"issue":"443\u201362","key":"10750_CR6","first-page":"vii","volume":"15","author":"N Hadzic","year":"2011","unstructured":"Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011;15(443\u201362):vii\u2013x","journal-title":"Clin Liver Dis"},{"key":"10750_CR7","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1002\/cncr.28903","volume":"120","author":"G-Y Hung","year":"2014","unstructured":"Hung G-Y, Horng J-L, Lee Y-S, Yen H-J, Chen C-C, Lee C-Y. Cancer incidence patterns among children and adolescents in Taiwan from 1995 to 2009: a population-based study. Cancer. 2014;120:3545\u20133553","journal-title":"Cancer"},{"key":"10750_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.3390\/cancers11111777","volume":"11","author":"B Dembowska-Bagi\u0144ska","year":"2019","unstructured":"Dembowska-Bagi\u0144ska B, Wi\u0119ckowska J, Bro\u017cyna A, \u015awi\u0119szkowska E, Ismail H, Broniszczak-Czyszek D, et al. Health status in long-term survivors of hepatoblastoma. Cancers. 2019;11:1777","journal-title":"Cancers"},{"key":"10750_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","volume":"48","author":"AJ Towbin","year":"2018","unstructured":"Towbin AJ, Meyers RL, Woodley H, Miyazaki O, Weldon CB, Morland B, et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol. 2018;48:536\u2013554","journal-title":"Pediatr Radiol"},{"key":"10750_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","volume":"52","author":"P Czauderna","year":"2016","unstructured":"Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, et al. The Children\u2019s Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer. 2016;52:92\u2013101","journal-title":"Eur J Cancer"},{"key":"10750_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29763","volume":"69","author":"JA Kahla","year":"2022","unstructured":"Kahla JA, Siegel DA, Dai S, Lupo PJ, Foster JH, Scheurer ME, et al. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer. 2022;69: e29763","journal-title":"Pediatr Blood Cancer"},{"key":"10750_CR12","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S1470-2045(18)30761-7","volume":"20","author":"N Bhakta","year":"2019","unstructured":"Bhakta N, Force LM, Allemani C, Atun R, Bray F, Coleman MP, et al. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019;20:e42-53","journal-title":"Lancet Oncol"},{"key":"10750_CR13","doi-asserted-by":"crossref","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133\u20132161.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"key":"10750_CR14","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;S0140\u20136736(24)00367\u20132."},{"key":"10750_CR15","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"10750_CR16","doi-asserted-by":"publisher","first-page":"e1700","DOI":"10.1016\/S2214-109X(23)00406-0","volume":"11","author":"C Frick","year":"2023","unstructured":"Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023;11:e1700\u2013e1712","journal-title":"Lancet Glob Health"},{"key":"10750_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamapediatrics.2023.2029","volume":"177","author":"K Zhang","year":"2023","unstructured":"Zhang K, Kan C, Han F, Zhang J, Ding C, Guo Z, et al. Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019. JAMA Pediatr. 2023;177:837\u2013846","journal-title":"JAMA Pediatr"},{"key":"10750_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.canep.2013.03.004","volume":"37","author":"JE Heck","year":"2013","unstructured":"Heck JE, Meyers TJ, Lombardi C, Park AS, Cockburn M, Reynolds P, et al. Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol. 2013;37:390\u2013395","journal-title":"Cancer Epidemiol"},{"key":"10750_CR19","first-page":"E555","volume":"131","author":"LS de Fine","year":"2012","unstructured":"de Fine LS, Schmidt LS, Rod NH, Schmiegelow K, L\u00e4hteenm\u00e4ki PM, Kogner P, et al. Hepatoblastoma in the Nordic countries. Int J Cancer. 2012;131:E555-561","journal-title":"Int J Cancer"},{"key":"10750_CR20","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamaoncol.2019.1215","volume":"5","author":"PJ Lupo","year":"2019","unstructured":"Lupo PJ, Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Canfield MA, et al. Association between birth defects and cancer risk among children and adolescents in a population-based assessment of 10 million live births. JAMA Oncol. 2019;5:1150\u20131158","journal-title":"JAMA Oncol"},{"key":"10750_CR21","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","volume":"378","author":"PR Brock","year":"2018","unstructured":"Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, et al. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss. N Engl J Med. 2018;378:2376\u20132385","journal-title":"N Engl J Med"},{"key":"10750_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013;14:834\u2013842","journal-title":"Lancet Oncol"},{"key":"10750_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(18)30895-7","volume":"20","author":"HM Katzenstein","year":"2019","unstructured":"Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children\u2019s Oncology Group, multicentre, phase 3 trial. Lancet Oncol. 2019;20:719\u2013727","journal-title":"Lancet Oncol"},{"key":"10750_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2741\/e395","volume":"4","author":"B Haeberle","year":"2012","unstructured":"Haeberle B, von Schweinitz D. Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. Front Biosci (Elite Ed). 2012;4:493\u2013498","journal-title":"Front Biosci (Elite Ed)"},{"key":"10750_CR25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01067","author":"H Eiso","year":"2020","unstructured":"Eiso H, Tomoro H, Kenichiro W, Kohmei I, Yuka U, Sho K, et al. Outcome and late complications of hepatoblastomas treated using the Japanese study group for pediatric liver tumor 2 protocol. J Clin Oncol. 2020. https:\/\/doi.org\/10.1200\/JCO.19.01067","journal-title":"J Clin Oncol"},{"key":"10750_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2009.02.053","volume":"286","author":"CP Wild","year":"2009","unstructured":"Wild CP, Montesano R. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Lett. 2009;286:22\u201328","journal-title":"Cancer Lett"},{"key":"10750_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/hum.2016.025","volume":"28","author":"W Li","year":"2017","unstructured":"Li W, Guo L, Rathi P, Marinova E, Gao X, Wu M-F, et al. Redirecting T cells to Glypican-3 with 4\u20131BB zeta chimeric antigen receptors results in Th1 polarization and potent antitumor activity. Hum Gene Ther. 2017;28:437\u2013448","journal-title":"Hum Gene Ther"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10750-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:45:18Z","timestamp":1740210318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10750-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10750"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10750-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}